Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration entities : Astellas pharma inc save search
Astellas Announces Strategic Collaboration with Mass General Brigham
Published: 2024-01-30 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.17 16K
|
Health Technology
|
| O: 4.34%
H: 0.0%
C: 0.0%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 0.0%
H: 1.38%
C: 0.26%
PFE A | $25.615 0.89% 9.9M
|
Health Technology
|
| O: 0.56%
H: 1.25%
C: -0.33%
collaboration
Vivtex Enters Research Collaboration with Astellas Pharma
Published: 2024-01-23 (Crawled : 15:30) - biospace.com/
ALPMF | $9.17 16K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -0.11%
H: 0.37%
C: -0.15%
pharma research collaboration
Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
Published: 2023-12-28 (Crawled : 06:00) - prnewswire.com
ALPMF | $9.17 16K
|
Health Technology
|
| O: -4.08%
H: 5.57%
C: 5.57%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 0.85%
H: 2.96%
C: 1.94%
license research collaboration agreement
Phenomic Enters into Strategic Research Collaboration with Astellas for Solid Tumor Cell Therapies
Published: 2023-11-30 (Crawled : 20:00) - biospace.com/
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 0.66%
H: 0.0%
C: -0.16%
cell tumor research collaboration
Astellas, BioLabs and Mitsui Fudosan Announce a Collaboration to Enhance the Life Science Ecosystems in Tsukuba and Kashiwa-no-ha, Japan
Published: 2023-10-11 (Crawled : 00:00) - prnewswire.com
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -3.81%
H: 5.97%
C: 2.57%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.02%
H: 0.1%
C: -0.06%
japan life collaboration
Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders
Published: 2023-07-25 (Crawled : 18:00) - biospace.com/
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -0.61%
H: 0.14%
C: 0.14%
license research protein collaboration agreement
Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders
Published: 2023-06-15 (Crawled : 07:00) - prnewswire.com
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -0.92%
H: 0.0%
C: -0.37%
protein collaboration agreement
ImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with Astellas
Published: 2023-03-30 (Crawled : 15:00) - biospace.com/
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -2.17%
H: 2.71%
C: 1.36%
IPA | $1.24 3.9K
|
Professional, Scientific, and T...
|
| O: 0.21%
H: 3.36%
C: 0.51%
license research collaboration agreement
Generian Achieves First Milestones in Mitobridge Collaboration
Published: 2023-02-08 (Crawled : 12:20) - prnewswire.com
ALPMF | $9.17 16K
|
Health Technology
|
| O: 3.31%
H: 0.0%
C: 0.0%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 0.55%
H: 0.21%
C: -0.41%
collaboration
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
Published: 2023-01-09 (Crawled : 13:20) - biospace.com/
ALPMF | $9.17 16K
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 0.58%
H: 0.44%
C: -0.31%
TWST | News | $28.77 1.45% 190K
|
Health Technology
|
| O: 2.24%
H: 0.24%
C: -5.08%
research collaboration antibody bioscience
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss
Published: 2022-07-05 (Crawled : 08:00) - prnewswire.com
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 1.44%
H: 0.39%
C: 0.39%
research collaboration
Generian and Astellas Enter into Collaboration and Exclusive License Agreement to Discover and Develop Novel Small Molecules For Undruggable Targets
Published: 2022-06-29 (Crawled : 12:00) - biospace.com/
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -5.08%
H: 3.46%
C: 2.81%
collaboration license agreement
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)
Published: 2022-06-27 (Crawled : 00:00) - globenewswire.com
ALPMF | $9.17 16K
|
Health Technology
|
| O: 5.56%
H: 0.0%
C: 0.0%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 1.88%
H: 0.0%
C: -0.68%
STRO M | $3.715 -1.46% 120K
|
Health Technology
|
| O: 15.01%
H: 14.86%
C: 5.02%
collaboration drug
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement
Published: 2022-01-31 (Crawled : 12:00) - biospace.com/
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -1.66%
H: 1.0%
C: 1.0%
air services collaboration
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Published: 2021-12-02 (Crawled : 01:00) - prnewswire.com
ALPMF | $9.17 16K
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: 4.84%
H: 0.0%
C: -2.25%
cardiac gene therapy research therapeutics therapy collaboration
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.3022 24.82% 51M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.